brilliantist-studio-shutterstock-com-brexit-

Brilliantist Studio / Shutterstock.com

7 December 2016Big Pharma

LSPN 2016: UPC Agreement hasn’t reached a safe harbour yet

The Unified Patent Court Agreement has not quite reached a safe harbour yet, but it is close.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Preventative IP for preventative pharma healthcare

Court denies Regeneron bid to halt copy of blockbuster eye drug

Interview: Klaus Grabinski, UPC Court of Appeal president

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Dexcom suffers second patent revocation at hands of UPC